✦ LIBER ✦

A double-blind trial of high versus conventional dosages of gold salts for rheumatoid arthritis

✍ Scribed by D. E. Furst; S. Levine; R. Srinivasan; A. L. Metzger; R. Bangert; H. E. Paulus

Publisher: John Wiley and Sons
Year: 1977
Tongue: English
Weight: 563 KB
Volume: 20
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.1780200805

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Double-blind trial of recombinant γ-inte

Double-blind trial of recombinant γ-interferon versus placebo in the treatment of rheumatoid arthritis

✍ Assistant Professor of Medicine Grant W. Cannon; Adjunct Associate Professor of 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 924 KB

The effects of intravenous doxycycline t

The effects of intravenous doxycycline therapy for rheumatoid arthritis: A randomized, double-blind, placebo-controlled trial

✍ E. William St.Clair; William E. Wilkinson; David S. Pisetsky; Daniel J. Sexton; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 2 views

The prosorba column for treatment of ref

The prosorba column for treatment of refractory rheumatoid arthritis: A randomized, double-blind, sham-controlled trial

✍ David T. Felson; Michael P. LaValley; Andrew R. Baldassare; Joel A. Block; Jacqu 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 3 views

A randomized, double-blind, 24-week cont

A randomized, double-blind, 24-week controlled study of low-dose cyclosporine versus chloroquine for early rheumatoid arthritis

✍ ROBERT B. M. Landewé; Henk S. Goeithè; ANDRE W. A. M. Van Rijthoven; Ferdinand C 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 752 KB

A 48-week, randomized, double-blind, dou

A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: Results of the METGO study

✍ Allen J. Lehman; John M. Esdaile; Alice V. Klinkhoff; Eric Grant; Avril Fitzgera 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 3 views

The safety and efficacy of a JAK inhibit

The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo

✍ Joel M. Kremer; Bradley J. Bloom; Ferdinand C. Breedveld; John H. Coombs; Mark P 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB 👁 3 views